B+
Bull case
20%
Probability
Target price
$5.50
Analysis reference price unavailable
Analysis 2026-08-04 · RankAlpha Sentiment Codex
CATX
Perspective TherapeuticsDNYSE American / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
Current thesis
Updated company materials support a potentially meaningful VMT-α-NET readout and registration-path narrative, with additional oncology programs providing optionality [#SEC-8K-2026-08-03].
Posture
Defensive
Lead driver
Sentiment
What changed
Sentiment remains the lead driver in the composite, 7D delta +3.7.
What can break
Early-stage clinical programs may fail to demonstrate sufficient efficacy or tolerability.
Momentum
27
Value
41
Sentiment
56
Setup hits (3d)
0 · Net Neutral
AI TargetsBase $2.60 · Bull $5.50 · Bear $1.35Analysis 2026-08-04; returns require an exact persisted reference.
Data freshness
Prices
Unavailable: Price unavailable
Fundamentals
As of 2026-08-17 • Vendor: Data Vendor v1
Scores
As of 2026-09-09 • Model: HYBRID_IC_RP
AI Memo
As of 2026-08-04 • Model: RankAlpha Sentiment Codex
Investment thesisAs of 2026-09-09
Investment thesis
As of 2026-09-09
Grade is the composite factor band; factor scores use a 0–100 scale. Confidence describes evidence quality, not a probability of return. Score date: 2026-09-09. Definitions
Supporting evidence
What
Grade D · Defensive
Confidence Medium · Net Neutral
Target $12.23
Why
Momentum27 · Δ7d -2.7
Value41 · Δ7d 0.0
Sentiment56 · Δ7d +3.7
So what
Weak posture (Net Neutral). Prioritize risk control and patience.
Confirming evidence
- • Sentiment remains the lead driver in the composite, 7D delta +3.7.
Contradictions & invalidation
- • Early-stage clinical programs may fail to demonstrate sufficient efficacy or tolerability.
- • Regulatory feedback may delay or weaken the path to registration.
- • CATX remains an early-stage, event-driven biotech with clinical, regulatory, execution, and financing risks.
Catalyst clock
2026-08-10
Q2 2026 results and business update
Lead driver: Sentiment · See AI snapshot
Momentum
27
9% active weight
Current posture
7d trendSoftening
Δ7d
-2.7
Δ21d
+5.2
Value
41
28% active weight
Current posture
7d trendFlat
Δ7d
0.0
Δ21d
+0.1
Sentiment
56
62% active weight
Current posture
7d trendImproving
Δ7d
+3.7
Δ21d
+3.2
Why this grade
Composite grade D. Momentum 26.6 / Value 41.2 / Sentiment 55.9
Scenario snapshot
Scenario probability is memo-authored likelihood, not forecast certainty. Targets belong to the analysis dated 2026-08-04. Scenario method
Most likely
B
Base case
50%
Probability
Target price
$2.60
Analysis reference price unavailable
Analysis 2026-08-04 · RankAlpha Sentiment Codex
B-
Bear case
30%
Probability
Target price
$1.35
Analysis reference price unavailable
Analysis 2026-08-04 · RankAlpha Sentiment Codex
Fundamentals (TTM)As of 2026-08-17
Fundamentals (TTM)
As of 2026-08-17
Market Cap
$367.57M
Beta
1.75
Shares Out
114.15M
P/E (TTM) · Derived
-2.3
P/S (TTM)
188.78
P/FCF (TTM) · Derived
-2.46
Rev YoY
-72.1%
EPS YoY
-23.3%
Gross Margin
-891.0%
Op Margin
-28174.1%
Net Debt
-$141.48M
Current Ratio
6.61
As of 2026-09-09 • Updated nightlySource: Internal modelMethods & Data